Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Certifies Empire Genomics, Welgene for Microarray Service Providers Program

NEW YORK (GenomeWeb News) — Agilent Technologies said yesterday it has signed on Empire Genomics and Welgene Biotech as new members of its Certified Microarray Service Providers program.
 
The program includes training and assessments with Agilent’s 60-mer oligo microarrays, the company said. The training systems for the Agilent platforms include quality control, sample preparation, hybridization, microarray analysis, and final data analysis.  
 
Empire Genomics is a personalized medicine company based in Buffalo, NY, and Welgene Biotech is a PCR and microarray-analysis company based in Taipei City, Taiwan.
 
Agilent also said it re-certified French RNA-splicing company ExonHit.
 
 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.